Streetbeat News

Products Services

BIOX

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) has received approval from the USDA for the cultivation of its drought-tolerant HB4 wheat in the U.S. The USDA's APHIS concluded that HB4 wheat does not pose an increased plant pest risk, allowing it to bypass certain regulations.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 1:04 pm

ACIU

Life Molecular Imaging, a partner of AC Immune, has received FDA Fast Track Designation for its PI-2620 Tau-PET diagnostic tool, which is used in three neurodegenerative conditions. This development could potentially accelerate the approval process and enhance the marketability of the diagnostic tool.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 1:03 pm

SEALSQ

SEALSQ is integrating its QS7001 quantum-resistant platform into the next generation of WISeSat satellites, with a prototype launch planned for November 2024. This integration aims to enhance space performance and secure communications.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 1:02 pm

AVGO

Broadcom has launched Rally Anywhere, an on-premises enterprise agility platform, at VMware Explore 2024. This platform aims to meet the compliance and security needs of global organizations.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 1:02 pm

ACN

Accenture Federal Services has secured a $75 million contract to enhance the use of AI in modernizing patent examinations at the USPTO.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 1:01 pm

ARQT

Arcutis Biotherapeutics (NASDAQ:ARQT) has received mixed analyst ratings over the past three months, with a recent decrease in the average price target by 4.17%. The company's lead product, ZORYVE roflumilast cream, has shown positive results in Phase 3 trials. Despite a significant revenue growth rate of 494.57%, the company faces challenges with a high debt-to-equity ratio and below-average ROE and ROA.

Portfolio Pulse from Benzinga Insights

August 28, 2024 | 1:00 pm

ANF

Abercrombie & Fitch is focusing on expanding its customer base in Europe and the Asia-Pacific (APAC) regions, as they believe they are under-penetrated in these markets.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:59 pm

ANF

Abercrombie & Fitch has observed that the wedding season has extended into the fall, which could impact their sales positively as demand for wedding-related apparel continues beyond the traditional summer months.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:53 pm

FTNT

Fortinet Inc. (NASDAQ:FTNT) has shown strong financial performance and technical indicators, suggesting potential for further gains. The company reported a revenue increase and earnings beat in Q2, and is expanding its Unified SASE solution with GenAI capabilities. A recent Golden Cross indicates bullish momentum, though caution is advised due to overbought signals.

Portfolio Pulse from Surbhi Jain

August 28, 2024 | 12:52 pm

XPEV

Xpeng (NYSE:XPEV) has announced the successful tape-out of its proprietary AI chip, Turing, which will be used in its electric vehicles, robots, and flying cars. This chip is designed for L4 autonomous driving and offers three times the computing power of the current chip. Despite this milestone, Xpeng shares are trading relatively flat.

Portfolio Pulse from Nabaparna Bhattacharya

August 28, 2024 | 12:47 pm